痴呆预立医疗照护计划的未来政策与研究:EAPC国际德尔菲共识建议
欧洲姑息治疗协会(EAPC)痴呆预立医疗照护计划(ACP)工作组开展四轮德尔菲研究,107名来自33个国家的专家于2021年9月至2022年6月达成11条共识建议,涉及预立医嘱监管、公平可及及痴呆包容性对话方法,并识别研究与政策缺口。
要点
- 共识涵盖预立医嘱监管、服务公平可及及痴呆包容性沟通方式。
- 研究缺口包括需建立痴呆特异性实践模型以优化决策支持。
- 政策缺口包括卫生服务框架对痴呆包容性实践支持不足。
核心结论
- 需更多证据和政策发展以支持包容性ACP实践模式。
研究设计与样本
- EAPC工作组开展四轮德尔菲研究,107名来自33个国家的专家参与,时间为2021年9月至2022年6月,经EAPC董事会批准。
主要发现
- 在预立医嘱监管、公平可及及痴呆包容性表达患者价值观的方法等11条建议上达成共识。
- 识别的研究缺口包括需建立基于证据的痴呆特异性实践模型,优化与能力波动或受损患者及其家庭的参与和沟通以支持决策,并赋能患者随时间调整决策。
- 识别的政策缺口包括卫生服务框架对痴呆包容性实践支持不足。
关键数值与推荐
- 达成共识的11条建议涉及预立医嘱监管、公平可及及痴呆包容性方法与对话以表达患者价值观。
临床怎么用
- 临床可参考共识建议推动痴呆患者ACP的公平可及与包容性沟通。
- 需关注患者能力波动,支持其随时间调整决策。
局限性
- 原文未报告德尔菲共识阈值及具体局限性声明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Advance care planning (ACP) is increasingly recognised in the global agenda for dementia care. The European Association for Palliative Care (EAPC) Taskforce on ACP in Dementia aimed to provide recommendations for policy initiatives and future research. We conducted a four-round Delphi study with a 33-country panel of 107 experts between September, 2021, and June, 2022, that was approved by the EAPC Board. Consensus was achieved on 11 recommendations concerning the regulation of advance directives, equity of access, and dementia-inclusive approaches and conversations to express patients' values. Identified research gaps included the need for an evidence-based dementia-specific practice model that optimises engagement and communication with people with fluctuating and impaired capacity and their families to support decision making, while also empowering people to adjust their decisions if their goals or preferences change over time. Policy gaps included insufficient health services frameworks for dementia-inclusive practice. The results highlight the need for more evidence and policy development that support inclusive ACP practice models.
引用
- Nakanishi M, Martins Pereira S, Van den Block L, et al. Future policy and research for advance care planning in dementia: consensus recommendations from an international Delphi panel of the European Association for Palliative Care. Lancet Healthy Longev. 2024. PMID: 38608695. doi:10.1016/S2666-7568(24)00043-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。